Corticosteroids in the treatment of Sydenham's chorea
L. N. Green
This is a retrospective study of the treatment of eight female patients
with Sydenham's chorea by corticosteroid administration. The rationale for
use of this medication is based on the concept that Sydenham's chorea is
caused by an indolent inflammation of the small vessels in the
caudate-putamen complex. All patients in this series responded to
corticosteroid treatment relatively rapidly, with considerable diminution
in abnormal movements. It is concluded that corticosteroid treatment of
this condition is effective and deserves wider use. This report should
serve as an impetus for more controlled studies.
Sydenham's Chorea: A Clinical Follow-Up of 65 Patients
Demiroren et al.
J Child Neurol 2007;22:550-554.
ABSTRACT
Are antibasal ganglia antibodies important, and clinically useful?
Martino et al.
PN 2007;7:32-41.
FULL TEXT
Treatment of Sydenham's Chorea with Intravenous Immunoglobulin, Plasma Exchange, or Prednisone
Garvey et al.
J Child Neurol 2005;20:424-429.
ABSTRACT
Dyskinesias and associated psychiatric disorders following streptococcal infections
Dale et al.
Arch. Dis. Child. 2004;89:604-610.
ABSTRACT
| FULL TEXT
Dementia-Like Presentation of Striatal Hypermetabolic State With Antistriatal Antibodies Responsive to Steroids
Leger et al.
Arch Neurol 2004;61:754-757.
ABSTRACT
| FULL TEXT
Autoimmunity and the basal ganglia: new insights into old diseases
Dale
QJM 2003;96:183-191.
ABSTRACT
| FULL TEXT
Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea
Church et al.
Neurology 2002;59:227-231.
ABSTRACT
| FULL TEXT
Antineuronal Antibodies in Rheumatic Chorea
Kotby et al.
CVI 1998;5:836-839.
ABSTRACT
| FULL TEXT